Rubinstein-Taybi syndrome: genes and variants
Explore variant evidence for Rubinstein-Taybi syndrome across 2 analyzed proteins (CREBBP, EP300). Linked ClinVar records include 15 pathogenic or likely pathogenic variants, 311 variants of uncertain significance and 139 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Rubinstein-Taybi syndrome
CREBBP: CREB-binding protein
It acetylates histones and integrates signals from many transcription factors to regulate developmental and activity-dependent gene expression. Germline loss-of-function variants cause Rubinstein-Taybi syndrome, while somatic alterations occur in several cancers.
15 ClinVar pathogenic / likely pathogenic and 448 uncertain variants in CREBBP have source records linked to Rubinstein-Taybi syndrome. Association strength is not clinical gene validity.
EP300: Histone acetyltransferase p300
It acetylates histones and transcription factors and acts as a central coactivator for developmental and stress-responsive transcription. Germline loss-of-function variants cause Rubinstein-Taybi syndrome type 2, while acquired alterations occur in several cancers.
0 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in EP300 have source records linked to Rubinstein-Taybi syndrome. Association strength is not clinical gene validity.
Where Rubinstein-Taybi syndrome variants cluster
- CREBBP Interaction with TRERF1 (positions 1460–1891): 10 of 15 ClinVar pathogenic / likely pathogenic variants, 3.8× more than its size predicts (a length-based count, not a validated hotspot).
- CREBBP CBP/p300-type HAT (positions 1323–1700): 8 of 15 ClinVar pathogenic / likely pathogenic variants, 3.5× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Rubinstein-Taybi syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CREBBP S1687F | 1687 | CBP/p300-type HAT | Pathogenic / likely pathogenic (★★) |
| CREBBP R1233K | 1233 | Pathogenic / likely pathogenic (★★) | |
| CREBBP C1240Y | 1240 | Pathogenic / likely pathogenic (★★) | |
| CREBBP E1278K | 1278 | Pathogenic / likely pathogenic (★★) | |
| CREBBP T1447I | 1447 | CBP/p300-type HAT | Pathogenic / likely pathogenic (★★) |
| CREBBP G1465E | 1465 | CBP/p300-type HAT | Pathogenic / likely pathogenic (★★) |
| CREBBP R1867Q | 1867 | Interaction with TRERF1 | Pathogenic / likely pathogenic (★★) |
| CREBBP R1868Q | 1868 | Interaction with TRERF1 | Pathogenic / likely pathogenic (★★) |
| CREBBP M1872T | 1872 | Interaction with TRERF1 | Pathogenic / likely pathogenic (★★) |
| CREBBP S1687P | 1687 | CBP/p300-type HAT | Pathogenic / likely pathogenic (★) |
| CREBBP L1142P | 1142 | Bromo | Pathogenic / likely pathogenic (★) |
| CREBBP H1470P | 1470 | CBP/p300-type HAT | Pathogenic / likely pathogenic (★) |
| CREBBP P1494S | 1494 | CBP/p300-type HAT | Pathogenic / likely pathogenic (★) |
| CREBBP Y1539N | 1539 | CBP/p300-type HAT | Pathogenic / likely pathogenic (★) |
| CREBBP K1520R | 1520 | CBP/p300-type HAT | Pathogenic / likely pathogenic (★) |
Which prediction tools work for Rubinstein-Taybi syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 98 out of 100
- MetaSVM: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 97 out of 100
- MutPred: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 91 out of 100
- PolyPhen-2: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 87 out of 100
Same protein, different disease
- Rubinstein-Taybi syndrome due to CREBBP mutations also has ClinVar records linked to CREBBP variants; they fall mostly in different places as the Rubinstein-Taybi syndrome variants (52 pathogenic / likely pathogenic).
- Menke-Hennekam syndrome also has ClinVar records linked to CREBBP variants; they fall mostly in different places as the Rubinstein-Taybi syndrome variants (15 pathogenic / likely pathogenic).
Diseases related to Rubinstein-Taybi syndrome
- Rubinstein-Taybi syndrome due to CREBBP mutations, also linked to CREBBP and EP300
- Menke-Hennekam syndrome, also linked to CREBBP and EP300
- Urinary bladder cancer, also linked to CREBBP and EP300
- Rare genetic intellectual disability, also linked to CREBBP and EP300
- Cone-rod dystrophy, also linked to CREBBP
- Colorectal cancer, also linked to EP300
- Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, also linked to EP300
- Colon carcinoma, also linked to EP300
- Head and neck squamous cell carcinoma, also linked to EP300
Frequently asked questions
Which genes have records linked to Rubinstein-Taybi syndrome?
This view contains 2 analyzed proteins: CREBBP, EP300. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 15 pathogenic or likely pathogenic variants, 311 variants of uncertain significance and 139 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 656 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center